APAC IPOs & Placements, Aequitas Research

Clarence Chu

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Sagility India IPO Trading - Lackluster Demand

Indegene IPO Trading - High Anchor Quality + Strong Demand, Expect a Pop on Debut

Sagility India Pre-IPO - Healthcare-Tech Exposure Although Alarming Concentration Risks to Watch For

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sagility-india" target="_blank" data-smartkarma-citation="entities:43717:1" rel="noopener">Sagility India (2058883D IN)</a> is looking to raise US$250m in its India IPO.</li>
<li>Sagility India (Sagility) is a pure-play healthcare focused solutions and services provider to Healthcare Payers and Providers.</li>
<li>In this note, we look at the RHP updates, undertake a peer comparison, and discuss our thoughts on valuation.</li>
</ul>



Sagility India (2058883D IN) is looking to raise US$250m in its India IPO.
Sagility India (Sagility) is a pure-play healthcare focused solutions and services provider to Healthcare Payers and Providers.
In this note, we look at the RHP updates, undertake a peer comparison, and discuss our thoughts on valuation.


Sagility India IPO - Hard to Ignore the Growing Concentration Risk